Swiss drugmaker Roche has signed a definitive merger agreement to acquire InterMune for around $8.3bn. As part of the all-cash...
Read moreNew JARDIANCE Simple Savings program currently offered in doctors' offices and online Jardiance® (empagliflozin) tablets are now available by prescription...
Read moreFOR EU MEDIA ONLY: NOT FOR SWISS/U.S. MEDIA EMA accepts accelerated review for orphan therapy in hard-to-treat thyroid cancer Eisai...
Read moreAustralia-based regenerative medicine company Mesoblast has signed an agreement with the US National Institutes of Health's (NIH) National Heart, Lung...
Read moreThe European Commission has given conditional marketing authorisation for biopharmaceutical company PTC Therapeutics' Translarna (ataluren) in the EU. Translarna is...
Read moreThe European Commission has granted orphan drug designation to Alexion Pharmaceuticals' Soliris (eculizumab), a terminal complement inhibitor, to treat patients...
Read moreBristol-Myers Squibb and Allied Minds have formed a new jointly owned enterprise, Allied-Bristol Life Sciences, aimed at advancing discoveries of...
Read moreAllowing pharma companies to earn excessive profit is against the principles of morality and ethics, the National Consumer Commission has...
Read moreThe US Food and Drug Administration (FDA) has approved Jardiance (empagliflozin) tablets, developed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly...
Read moreThe European Commission has approved Vertex Pharmaceuticals' oral medicine Kalydeco (ivacaftor) for people with cystic fibrosis (CF). Kalydeco is for...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
